Recent Advances for Cell / Gene Therapy in Rheumatoid Arthritis

ISSN: 1875-614X (Online)
ISSN: 1871-5230 (Print)

Volume 16, 3 Issues, 2017

Download PDF Flyer

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Claudiu T. Supuran
Neurofarba Department
University of Florence

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Recent Advances for Cell / Gene Therapy in Rheumatoid Arthritis

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 3(2): 119-138.

Author(s): F. Apparailly, P. Plence, D. Noel and C Jorgensen.

Affiliation: INSERM U475, 99 rue Puech Villa, and 2 service d'Immuno-rhumatologie, CHU Lapeyronie, Montpellier,France


Great progress has been made in recent years in the management of patients with autoimmune diseases, such as rheumatoid arthritis (RA). This progress is largely due to the advances in our understanding of cellular and molecular mechanisms involved in the pathogenesis of inflammation and autoimmunity, and the improved knowledge of molecular biology. Immunotherapy has the potential to modify or re-balance the immune system and hence useful in the management of autoimmune conditions. In this review, we first focus on new biotherapies currently developed in clinic for the treatment of RA. We also outline the limitations of such approaches and review perspectives raised by the current studies on innovative alternatives, such as gene and cell therapy. Immuno-modulation through dendritic cells or mesenchymal stem cells, functionally and / or genetically modified, is under increasing number of investigations and thus will also be discussed. Strategies include the inhibition of pro-inflammatory cytokines, blockade of cartilage-degrading enzymes, inhibition of synovial cell activation or apoptosis of synovial cells and manipulation of the Th1-Th2 cytokine balance. Both viral and non-viral gene transfer vector systems have been used to deliver therapeutic genes systemically or directly to arthritic joints. Animal models of RA have been essential not only for better understanding of the RA mechanisms, but also in serving as basic experimental tools to evaluate candidate gene products with anti-arthritic properties and develop therapeutic strategies. Better understanding of autoimmune mechanisms, advances in vectorology, and combination of immunosuppressive gene / cell therapies promise better immunotherapy for RA in the near future.


rheumatoid arthritis, immunotherapy, dendritic cells, stem cells, gene therapy.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 3
Issue Number: 2
First Page: 119
Last Page: 138
Page Count: 20
DOI: 10.2174/1568014043355410
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science